NCT07241962Not yet recruiting
Hepatitis B and C Within the Chinese Community in Milan
Prevalence of Hepatitis B and C Within the Chinese Community Residing in Milan
Source: ClinicalTrials.gov · Last updated 21 Nov 2025
Brief summary (registry, in English)
The goal of this observational study is to assess the effectiveness of targeted screening for Hepatitis B (HBV) and Hepatitis C (HCV) infections in adults aged 18 to 50 from the Chinese community residing in Milan. The main questions it aims to answer are: * Does community-based, culturally sensitive screening increase the detection of undiagnosed HBV and HCV infections in this high-risk population? * What is the level of adherence, satisfaction and awareness regarding rapid testing methods in this community? Participants will: * Receive pre-test counseling in Italian or Chinese with the help of an interpreter * Complete a brief, anonymous questionnaire on demographics, risk factors and awareness of HBV/HCV * Undergo capillary rapid testing for HBV and/or HCV * Receive test results during the same visit * Complete a short post-test satisfaction questionnaire The study will be conducted in public spaces within Milan's Chinatown, during monthly sessions, until 1,000 participants are enrolled. Each session will last approximately 30-60 minutes per participant.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 1000 (estimated)
- First submitted
- 17 Nov 2025
- Start date
- Dec 2025
- Primary completion date
- Dec 2026
- Lead sponsor
- IRCCS Ospedale San Raffaele
- Diseases
- Hepatitis B
- NCT number
- NCT07241962
What you commit to
- Study type: Observational
- Planned participants: 1000
- From Dec 2025 to the primary completion date, Dec 2026
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Currently undergoing treatment for HBV or HCV, or with previously confirmed diagnosis of HBV or HCV
Other illness
- Severe mental or physical illness impairing participation or understanding of consent
Age
- Age under 18 or over 50 years
Other
- Not from the Chinese community or not residing in Milan
- Unable to provide informed consent
- Unable to respond to the questionnaire, even with interpreter assistance
- Pregnant women
Who the study is looking for
- Adults aged 18 to 50 years
- Self-identified as part of the Chinese community residing in Milan
- Willing and able to provide informed consent
- Willing to undergo HBV and/or HCV rapid screening (capillary blood test)
- Able to complete an anonymous questionnaire on demographics, risk factors and awareness of HBV and HCV infections
- Able to communicate in Italian or Chinese (with interpreter assistance, if needed)
Age in the registry: 18 years to 50 years · Sex: All · Accepts healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.